ScholarIQanswers from OpenAlex

Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity

PaperCitations, authors & open-access status

Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity have?

ScholarIQcitation count

Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity has 30 citations in the OpenAlex counts ScholarIQ stores.

When was Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity published?

ScholarIQyear

Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity has 2022 year in the ScholarIQ index.

What is the open-access status of Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity?

ScholarIQoa status

Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity has gold oa status in the ScholarIQ index.

What is the DOI of Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity?

ScholarIQdoi

The DOI for Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity is on the source record.

What is the PMID of Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity?

ScholarIQpmid

The PMID for Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity is on the source record.

What is the OpenAlex record for Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity?

ScholarIQopenalex

The OpenAlex for Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial